
Cardiology
Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.
No claims extracted for this topic
Immunologically induced acute synovitis in rabbits studies of immune complexes in synovial fluid
Arthritis & Rheumatism — Hollister J — Jan 1973
Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats.
Stroke — Nag S — Oct 1991
TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the rat
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology — Bertolino F — Feb 1995
Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I
Scandinavian Journal of Clinical and Laboratory Investigation — Sygitowicz G — Jan 2013
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Sermorelin (also known as Sermorelin, GHRH 1-29, growth hormone releasing factor 1-29). Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.
As of 2026-08-18, the scientific consensus on Sermorelin is unknown. No claims extracted for this topic
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-sermorelin.
Deterministic synthesis from Synapse's enriched corpus — 54 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Sermorelin paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Sermorelin papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers
Salk Institute for Biological Studies
h-index 160 · 105k citations
Most-cited researchers publishing on Sermorelin.